News – Page 846 – Endpoints News

Sanofi walks back Paul Hudson’s promise of early vaccine access for the US, French ministers call it 'unacceptable'

6 years ago

Merck pours $400M into flea drugs for Fido; Avrobio shows durability; Rhythm gets priority review

6 years ago

One year on, Capricor's stem cell therapy appears to help DMD patients in small study, but investors balk at the data

6 years ago

Boehringer Ingelheim sharpens retinal strategy, scooping up dry AMD drug from a Swiss team behind Novartis' Beovu

6 years ago

Sanofi flashes more PhIII data on new multiple myeloma drug, setting up battle with Darzalex

6 years ago

FDA slams bluebird and Bristol Myers with a surprise RTF on ide-cel, but execs insist they can overcome setback ...

6 years ago

(Another) activist attack on Alexion, as Paul Singer-founded hedge fund calls for biotech to sell itself

6 years ago

The new CEO at troubled AMAG begins his battle against an array of threats by axing staff and slashing costs

6 years ago

Covid-19 roundup: Paul Hudson says US will have first dibs on Sanofi vaccine; Gilead selects 5 generic manufacturing ...

6 years ago

Precision therapy approach secures small biotech $42M haul to combat disease that inspired the Ice Bucket Challenge

6 years ago

FDA issues two guidances to accelerate Covid-19 treatments

6 years ago

Chinese biotech aims $232M in IPO cash to push next-gen prostate cancer drug; Immunomedics raises nearly a ...

6 years ago

Positive pivotal cell graft data bring Novartis-backed Boston biotech step closer to finish line

6 years ago

With money flowing, Pliant Therapeutics heads to public well

6 years ago

Merck doubles down on Skyhawk's tech to drug RNA, promising $600M per autoimmune, metabolic target

6 years ago

Vivek Ramaswamy’s brother, Shankar, spins out on his own, launching audacious gene therapy play

6 years ago

Covid-19 roundup: The FDA gives Moderna’s Covid-19 team a regulatory embrace to go along with the cheers and jeers; ...

6 years ago

Ex-DARPA chief Regina Dugan, former Illumina CEO Jay Flatley lead $300M Wellcome Trust fund to tackle global health's ...

6 years ago

Genfit's NASH drug fails a closely-watched PhIII showdown, adding one more setback to a plagued field

6 years ago

CEPI bets $384M on Novavax’s Covid-19 vaccine — covering R&D and manufacturing in the groundbreaking race to beat ...

6 years ago

Merck to move global headquarters, returning to an old home

6 years ago

Fritz Gerber, who led Roche for 2 decades, dies; ADC Therapeutics tries again for an IPO, sets terms

6 years ago

'We're good to go': MyoKardia clinches crucial PhIII win, boosting genetic approach to cardio R&D

6 years ago

Small biotech Oyster Point sets up pitch to disrupt dry eye market with nasal spray

6 years ago

First page Previous page 843 844 845846847 848 849 Next page Last page